海王生物
(000078)
| 流通市值：61.19亿 | | | 总市值：64.09亿 |
| 流通股本：26.26亿 | | | 总股本：27.51亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 8,087,937,989.71 | 36,418,770,306.16 | 28,640,393,734.42 | 19,953,807,547.43 |
| 营业收入 | 8,087,937,989.71 | 36,418,770,306.16 | 28,640,393,734.42 | 19,953,807,547.43 |
| 二、营业总成本 | 7,981,269,889.39 | 36,503,984,042.96 | 28,340,184,524.32 | 19,699,182,312.57 |
| 营业成本 | 7,245,189,928.1 | 32,865,445,209.55 | 25,683,929,041.52 | 17,863,525,109.91 |
| 税金及附加 | 22,928,320.76 | 107,023,923.22 | 77,711,143.67 | 51,968,260.54 |
| 销售费用 | 282,240,166.46 | 1,390,073,485.34 | 1,066,207,615.14 | 755,558,781.1 |
| 管理费用 | 241,419,534.28 | 1,149,882,564.47 | 887,488,612.86 | 599,008,672.98 |
| 研发费用 | 10,122,756.35 | 47,938,144.82 | 37,110,222.28 | 23,003,143.21 |
| 财务费用 | 179,369,183.44 | 943,620,715.56 | 587,737,888.85 | 406,118,344.83 |
| 其中:利息费用 | 205,615,289.37 | 945,944,671.94 | 629,652,016.9 | 430,468,506.4 |
| 其中:利息收入 | 27,569,817.29 | 48,791,229.42 | 67,936,638.4 | 42,349,602.06 |
| 加:公允价值变动收益 | 115,975.62 | 17,752,259.55 | 282,609.11 | 425,930.5 |
| 加:投资收益 | -8,007,570.45 | -45,417,836.01 | 25,825,105.42 | 24,393,439.49 |
| 资产处置收益 | 602,905.61 | 3,237,874.71 | 1,970,755.17 | 544,973.44 |
| 资产减值损失(新) | 956,100.6 | -962,354,680.99 | -2,918,418.39 | -117,095.77 |
| 信用减值损失(新) | 15,708,477.13 | -423,166,269.24 | -11,585,203.56 | -21,781,476.54 |
| 其他收益 | 5,716,405.89 | 27,132,469.03 | 15,597,715.04 | 13,310,278.52 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 121,760,394.72 | -1,468,029,919.75 | 329,381,772.89 | 271,401,284.5 |
| 加:营业外收入 | 1,794,416.78 | 25,025,619.79 | 19,368,772.99 | 13,060,253.32 |
| 减:营业外支出 | 1,916,688.18 | 15,469,995.21 | 6,794,257.59 | 4,463,964.72 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 121,638,123.32 | -1,458,474,295.17 | 341,956,288.29 | 279,997,573.1 |
| 减:所得税费用 | 52,466,567.19 | 260,558,561.15 | 155,946,988.51 | 116,020,010.98 |
| 六、净利润 | 69,171,556.13 | -1,719,032,856.32 | 186,009,299.78 | 163,977,562.12 |
| 持续经营净利润 | 69,171,556.13 | -1,719,032,856.32 | 186,009,299.78 | - |
| 归属于母公司股东的净利润 | 42,641,426.53 | -1,689,944,687.46 | 88,482,060.79 | 87,678,709.12 |
| 少数股东损益 | 26,530,129.6 | -29,088,168.86 | 97,527,238.99 | 76,298,853 |
| (一)基本每股收益 | 0.02 | -0.64 | 0.03 | 0.03 |
| (二)稀释每股收益 | 0.02 | -0.64 | 0.03 | 0.03 |
| 八、其他综合收益 | - | -17,430,000 | - | - |
| 归属于母公司股东的其他综合收益 | - | -17,430,000 | - | - |
| 九、综合收益总额 | 69,171,556.13 | -1,736,462,856.32 | 186,009,299.78 | 163,977,562.12 |
| 归属于母公司股东的综合收益总额 | 42,641,426.53 | -1,707,374,687.46 | 88,482,060.79 | 87,678,709.12 |
| 归属于少数股东的综合收益总额 | 26,530,129.6 | -29,088,168.86 | 97,527,238.99 | 76,298,853 |
| 公告日期 | 2024-04-30 | 2024-04-30 | 2023-10-30 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |